TITLE

OXO CHEMIE AG INITIATES MACROKINE PHASE 2 CLINICAL TRIALS

PUB. DATE
August 2000
SOURCE
Worldwide Biotech;Aug2000, Vol. 12 Issue 8, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that OXO Chemie AG has initiated the Phase 2 clinical trials of their macrophage-regulating drug, Macrokine in patients with hepatitis C virus disease.
ACCESSION #
3449623

 

Related Articles

  • WF 10: Macrokine, TCDO, Tetrachlorodecaoxide. Adis International Limited // Drugs in R&D;2004, Vol. 5 Issue 4, p242 

    WF 10 [TCDO, Oxoferin®, Immunokine™, Macrokine™] is a 1 : 10 dilution of tetrachlorodecaoxide formulated for IV delivery. It was developed by Oxo Chemie in Switzerland as an adjunctive therapy to combination antiretroviral and opportunistic infection prophylaxis regimens in AIDS...

  • Drug testing. Taibbi, Robert // Current Health 2;Mar1993, Vol. 19 Issue 7, p22 

    Presents facts on drug testing. Urine sampling; Drug screening of employees, athletes and former drug addicts undergoing treatment; Blood testing for alcohol; Privacy versus protection.

  • Drugs studied in children.  // FDA Consumer;Mar1991, Vol. 25 Issue 2, p6 

    Lists various drugs that are currently undergoing Food and Drug Administration-sanctioned testing for use in children with AIDS and related disorders.

  • Under the influence of poppy seeds.  // Tufts University Diet & Nutrition Letter;May92, Vol. 10 Issue 3, p2 

    Covers a report by James L. Abelson in the `Journal of the American Medical Association,' in which he states that a women was denied a job because urine samples tested positive for opiates after she had eaten a lemon poppy seed muffin. Effects of opiates; Amount of the drug found in poppy seed...

  • Japan criticised for unsafe drug licenses. Guest, Robert // BMJ: British Medical Journal (International Edition);12/9/95, Vol. 311 Issue 7019, p1521 

    Reports on criticisms against Japan's system for testing and licensing of medicines. Cases of fatal reactions to drugs prescribed with official approval; Comments from Nagoya-based Aichi Cancer Centre doctor Masanori Fukushima; Problems by th ministry of health and welfare.

  • What to do when your service has been declared `cost-ineffective'. Basskin, Lorne // Formulary;Oct96, Vol. 31 Issue 10, p933 

    Offers methods for standardization of drug evaluation for inclusion on clinical pathways. Evaluation of cost-effectiveness of several clinical services; Suggestions on how to address pharmacoeconomic dilemma; Elements of a pharmacoeconomic study.

  • The federal demonstration program of mandatory drug testing. Cadig, T.P. // Federal Probation;Mar1992, Vol. 56 Issue 1, p22 

    Discusses the impact and statistical results which have resulted from the mandatory drug testing policy implemented for criminal defendants in eight Federal judicial courts ordered by Section 7304 of the Anti-Drug Abuse Act of 1988. Implementation of drug testing prior to a defendant's initial...

  • Theophylline and behavior.  // Pediatrics for Parents;1992, Vol. 13 Issue 5, p1 

    Presents a study determining the effects of theophylline on children's behavior. Theophylline a drug often used to treat asthma; Parents believed theophylline adversely affected their children's behavior; Laboratory testing found no changes in test scores; Incongruity basis for second study;...

  • Theophylline precautions.  // Pediatrics for Parents;1992, Vol. 13 Issue 6, p3 

    Reports on theophylline, one of the mainstays of asthma treatment. Safe and effective when used properly; Narrow margin of safety; Potential side effects; Factors affecting rate the body breaks down theophylline; Recommendations by Committee on Drugs of the American Academy of Pediatrics;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics